Skip to main content
main-content

15-04-2018 | Juvenile idiopathic arthritis | Article

Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis

Cecchin V et al. J Rheumatol 2018; Advance online publication. doi: 10.3899/jrheum.171006

Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.

https://doi.org/10.3899/jrheum.171006

Related topics